Dianthus Therapeutics (DNTH) 8-K Summary

Filing Date: November 3, 2025

Dianthus Therapeutics reported the release of an updated Corporate Presentation on its investor relations website (Exhibit 99.1).

• This 8-K filing itself contains no specific financial metrics, strategic guidance, or material business disclosures.
• All substantive operational and forward-looking information must be reviewed within the referenced Presentation (Exhibit 99.1).
• The filing includes a standard cautionary note regarding forward-looking statements within the Presentation.

**Investor